Dare Bioscience/$DARE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Dare Bioscience
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Ticker
$DARE
Sector
Primary listing
Employees
23
Headquarters
Website
Dare Bioscience Metrics
BasicAdvanced
$31m
-
-$0.95
1.02
-
Price and volume
Market cap
$31m
Beta
1.02
52-week high
$9.19
52-week low
$1.27
Average daily volume
428k
Financial strength
Current ratio
1.026
Quick ratio
0.891
Long term debt to equity
813.526
Total debt to equity
978.022
Profitability
EBITDA (TTM)
-9.957
Gross margin (TTM)
194.95%
Net profit margin (TTM)
-1,038.77%
Operating margin (TTM)
-1,034.40%
Revenue per employee (TTM)
$50,000
Management effectiveness
Return on assets (TTM)
-32.21%
Return on equity (TTM)
272.30%
Valuation
Price to revenue (TTM)
22.683
Price to book
41.27
Price to tangible book (TTM)
41.27
Price to free cash flow (TTM)
-2.583
Free cash flow yield (TTM)
-38.72%
Free cash flow per share (TTM)
-0.805
Growth
Revenue change (TTM)
4,366.48%
Earnings per share change (TTM)
388.23%
3-year revenue growth (CAGR)
-51.27%
3-year earnings per share growth (CAGR)
-39.59%
What the Analysts think about Dare Bioscience
Analyst ratings (Buy, Hold, Sell) for Dare Bioscience stock.
Dare Bioscience Financial Performance
Revenues and expenses
Dare Bioscience Earnings Performance
Company profitability
Dare Bioscience News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs